Recent 13F filings as of September 2025 show that 27 institutional investors hold a position in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Beutel, Goodman & Co Ltd. | 30 Sep, 2025 | 4,058,899 | 4,058,899 | 0.00% | $23,920.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 30 Sep, 2025 | 1,350,000 | 1,350,000 | 0.00% | $7,965,000.00 |
| Vivo Capital, LLC | 30 Sep, 2025 | 1,350,000 | 1,350,000 | 0.00% | $7,965,000.00 |
| SCOTIA CAPITAL INC. | 30 Sep, 2025 | 1,277,885 | -14,104 | -1.09% | $7,254,710.00 |
| GREAT POINT PARTNERS LLC | 30 Sep, 2025 | 1,200,000 | 1,200,000 | 0.00% | $7,080,000.00 |
| Ally Bridge Group (NY) LLC | 30 Sep, 2025 | 915,000 | 915,000 | 0.00% | $5,398,500.00 |
| Logos Global Management LP | 30 Sep, 2025 | 900,000 | 900,000 | 0.00% | $5,310,000.00 |
| ROYAL BANK OF CANADA | 30 Sep, 2025 | 428,804 | 220 | 0.05% | $2,530,000.00 |
| Velan Capital Investment Management LP | 30 Sep, 2025 | 352,000 | 352,000 | 0.00% | $2,076,800.00 |
| Affinity Asset Advisors, LLC | 30 Sep, 2025 | 300,000 | 300,000 | 0.00% | $1,770,000.00 |
| Alyeska Investment Group, L.P. | 30 Sep, 2025 | 250,000 | 250,000 | 0.00% | $1,475,000.00 |
| UBS Group AG | 30 Sep, 2025 | 95,756 | 58,257 | 155.36% | $564,960.00 |
| INGALLS & SNYDER LLC | 30 Sep, 2025 | 59,100 | 21,900 | 58.87% | $349.00 |
| BANK OF AMERICA CORP /DE/ | 30 Sep, 2025 | 45,577 | 33,018 | 262.90% | $268,904.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 40,100 | 300 | 0.75% | $236,590.00 |
| BANK OF MONTREAL /CAN/ | 30 Sep, 2025 | 37,250 | 0 | 0.00% | $219,431.00 |
| RAYMOND JAMES FINANCIAL INC | 30 Sep, 2025 | 33,373 | 21,161 | 173.28% | $196,901.00 |
| Guardian Partners Inc. | 30 Sep, 2025 | 24,130 | 24,130 | 0.00% | $147,409.00 |
| ACADIAN ASSET MANAGEMENT LLC | 30 Sep, 2025 | 21,400 | 21,400 | 0.00% | $125.00 |
| JPMORGAN CHASE & CO | 30 Sep, 2025 | 16,467 | -2,250 | -12.02% | $97,155.00 |